Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans

article

Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/V10090480
P932PMC publication ID6164826
P698PubMed publication ID30205518

P50authorAnavaj SakuntabhaiQ17916848
Félix G DelgadoQ54377995
Claude RothQ59146351
Etienne Simon-LoriereQ29460611
Jaime Eduardo CastellanosQ39559697
P2093author name stringConsuelo Romero-Sánchez
Karina I Torres
P2860cites workZika virus. I. Isolations and serological specificityQ22240545
Zika Virus Outbreak on Yap Island, Federated States of MicronesiaQ22250881
Zika Virus Outbreak, Bahia, BrazilQ22330702
First report of autochthonous transmission of Zika virus in BrazilQ22330715
Co-infection with Zika and dengue viruses in 2 patients, New Caledonia, 2014Q22330724
Zika Virus, French Polynesia, South Pacific, 2013Q22330743
Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013Q22330748
Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control studyQ23012849
Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective studyQ24255260
Phylogeny of the genus FlavivirusQ24471099
Zika Virus Disease in Colombia — Preliminary ReportQ24653922
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virusQ24737245
Structural basis of potent Zika–dengue virus antibody cross-neutralizationQ24740325
Human antibody responses after dengue virus infection are highly cross-reactive to Zika virusQ25161212
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika VirusQ26247258
Easy and inexpensive molecular detection of dengue, chikungunya and zika viruses in febrile patientsQ26252062
Specificity, cross-reactivity and function of antibodies elicited by Zika virus infectionQ26252507
Early T-cell responses to dengue virus epitopes in Vietnamese adults with secondary dengue virus infectionsQ27469477
Differential Functional Avidity of Dengue Virus-Specific T-Cell Clones for Variant Peptides Representing Heterologous and Previously Encountered SerotypesQ27481452
Microcephaly in north-east Brazil: a retrospective study on neonates born between 2012 and 2015Q27927987
Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteinsQ28119724
Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in MiceQ28223043
Zika Virus Seroprevalence, French Polynesia, 2014–2015Q28310404
Dengue virus antibodies enhance Zika virus infectionQ28353949
Dengue: knowledge gaps, unmet needs, and research prioritiesQ28729764
Analysis of the T Cell Response to Zika Virus and Identification of a Novel CD8+ T Cell Epitope in Immunocompetent MiceQ28833083
Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cellsQ28950660
Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus InfectionQ29051494
Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunityQ29196526
Adaptive Immune Responses to Zika Virus Are Important for Controlling Virus Infection and Preventing Infection in Brain and TestesQ29365210
Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathologyQ29994510
Zika virus evolution and spread in the AmericasQ30145571
Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoesQ30145601
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and MexicoQ30145646
Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virusQ33850577
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF.Q34165624
Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection.Q34518791
The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopesQ34992520
Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune seraQ35294150
Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunityQ35701686
Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identificationQ36260214
NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasetsQ36742441
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cellsQ36895622
CD8(+) T Cell Immune Response in Immunocompetent Mice during Zika Virus InfectionQ38156594
Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.Q38156674
Impact of prior flavivirus immunity on Zika virus infection in rhesus macaquesQ38157106
T cell immunity to dengue virus and implications for vaccine design.Q38631171
Prediction of promiscuous T-cell epitopes in the Zika virus polyprotein: An in silico approachQ38820777
Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based techniqueQ39008705
Measurement of antibody-dependent infection enhancement of four dengue virus serotypes by monoclonal and polyclonal antibodiesQ39268319
From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoproteinQ40053057
Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine developmentQ40053684
A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood.Q40099738
Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccineQ40527785
Prior Dengue virus exposure shapes T cell immunity to Zika virus in humansQ41924182
Aminopeptidase substrate preference affects HIV epitope presentation and predicts immune escape patterns in HIV-infected individualsQ42187290
An evolutionary NS1 mutation enhances Zika virus evasion of host interferon inductionQ47548142
Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika virusesQ47549528
Sustained specific and cross-reactive T cell responses to Zika and Dengue viruses NS3 in West AfricaQ47555900
Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL.Q47558388
Antibody-dependent enhancement of severe dengue disease in humansQ47592202
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectvirologyQ7215
infectious diseaseQ18123741
Zika virusQ202864
Zika virus infectionQ27043680
P5008on focus list of Wikimedia projectWikiProject Zika CorpusQ54439832
P304page(s)480
P577publication date2018-09-07
P1433published inVirusesQ7935305
P1476titleImproved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans
P478volume10